Baker Bros. Advisors LP Oyster Point Pharma, Inc. Transaction History

Baker Bros. Advisors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.6 - $11.2 $221,126 - $687,948	-61,424 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$18.13 - $25.18 $123,356 - $171,324	-6,804 Reduced 9.97%	61,424 $1.16 Million
Q3 2020 Nov 16, 2020	SELL	$17.83 - $29.12 $57,055 - $93,184	-3,200 Reduced 4.48%	68,228 $1.44 Million
Q2 2020 Aug 14, 2020	BUY	$27.86 - $35.93 $1.99 Million - $2.57 Million	71,428 New	71,428 $2.06 Million

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.